End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41,550 KRW | +19.23% | +30.25% | +261.30% |
2023 | S.Biomedics CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2023 | S.Biomedics CO., LTD. has completed an IPO in the amount of KRW 13.5 billion. | CI |
Sales * | - | Sales 1 * | - | Capitalization | 130B 95.83M |
---|---|---|---|---|---|
Net income * | - | Net income 1 * | - | EV / Sales * | - |
Net cash position * | - 0 | Net cash position 1 * | - 0 | EV / Sales 1 * | - |
P/E ratio * |
-
| P/E ratio 1 * |
-
| Employees | - |
Yield * |
-
| Yield 1 * |
-
| Free-Float | 70.22% |
1 day | +19.23% | ||
1 week | +34.68% | ||
Current month | +21.85% | ||
1 month | +25.72% | ||
3 months | +315.08% | ||
6 months | +454.74% | ||
Current year | +261.30% |
Managers | Title | Age | Since |
---|---|---|---|
Sae-Il Kang
CEO | Chief Executive Officer | 44 | 18-03-28 |
Dong-Wook Kim
CEO | Chief Executive Officer | 63 | 19-03-30 |
Myung-Soo Cho
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-03-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sae-Il Kang
CEO | Chief Executive Officer | 44 | 18-03-28 |
Dong-Wook Kim
CEO | Chief Executive Officer | 63 | 19-03-30 |
Myung-Soo Cho
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-03-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 41,550 | +19.23% | 2,054,546 |
24-05-27 | 34,850 | -9.95% | 611,393 |
24-05-24 | 38,700 | -0.39% | 1,123,302 |
24-05-23 | 38,850 | +29.93% | 1,868,957 |
24-05-22 | 29,900 | -6.27% | 398,556 |
End-of-day quote Korea S.E., May 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+261.30% | 293M | |
-1.64% | 90.28B | |
-1.97% | 39.5B | |
-15.47% | 31.71B | |
+61.28% | 26.41B | |
-22.81% | 14.34B | |
-8.82% | 12.89B | |
-11.77% | 11.8B | |
-45.97% | 10.95B | |
+3.30% | 8.85B |
- Stock Market
- Equities
- A304360 Stock